Optical diagnosis of small colorectal polyps during colonoscopy: when to resect and discard?
Colonoscopy with polypectomy has been shown to be effective in reducing incidence and mortality from colorectal cancer (CRC). The increase in use of colonoscopy in national bowel cancer screening programmes combined with improved technology has resulted in a large increase in detection of polyps. Most polyps detected at screening colonoscopy are small (<10 mm) or diminutive (<6 mm) and, in particular the latter, have a very small chance of containing advanced features or cancer. The main reason for resecting small adenomas and sending them to histopathology serves to inform on the future surveillance intervals. Being able to diagnose adenomas in vivo would allow for them to be resected and discarded, saving the costs associated with histopathology. Diagnosing distal hyperplastic polyps in vivo would allow for these to be left in situ reducing the risks associated with polypectomy. There are now a number of new technologies that could potentially make optical diagnosis a reality. Resect and discard policy is an attractive concept for patients, gastroenterologists and health service providers and would present an enticing change to current clinical practice.